-
Sector Analysis
KRAS Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
The KRAS Market Report Overview The KRAS market size was $37.1 million in 2023. Factors such as product innovation will drive the market growth at a CAGR of more than 7% from 2023 to 2033. KRAS are devices used to inject contrast media agents into a patient's bloodstream. This process enables the visualization of various pathologies through X-ray, computed tomography, magnetic resonance, or other medical imaging devices. CT Injectors, MRI Injectors, and Angiographic Injectors have been included in this category....
-
Product Insights
Image Guided Surgery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Image Guided Surgery Pipeline Market Report Overview Image Guided Surgery devices use real-time images during surgery to assist surgeons in precisely guiding the surgical instruments to the anatomic structures. It helps minimize the chances of errors and reduce the procedure time. The Image Guided Surgery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are...
-
Product Insights
Contrast Agents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Contrast Agents Pipeline Market Report Overview The Contrast Agents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Positron Emitting Tomography Contrast Agents ·       Magnetic Resonance Imaging (MRI) Contrast Agents ·       Gadolinium-based MRI Contrast Agents...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golimumab in Type 1 Diabetes (Juvenile Diabetes)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Golimumab in Type 1 Diabetes (Juvenile Diabetes) Drug Details:Golimumab (Simponi) is a human monoclonal antibody, acts...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Upadacitinib ER in Systemic Idiopathic Juvenile Arthritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Upadacitinib ER in Systemic Idiopathic Juvenile Arthritis Drug Details: Upadacitinib (Rinvoq, Rim-Voq) is an antineoplastic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Etanercept Biosimilar in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Etanercept Biosimilar in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Etanercept Biosimilar in Rheumatoid ArthritisDrug Details:Etanercept (Rymti, Etera, Nepexto) is a dimeric...
-
Product Insights
Nuclear Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Nuclear Imaging Equipment Pipeline Market Report Overview Nuclear Imaging Equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis. The nuclear imaging equipment...
-
Sector Analysis
Diagnostic Imaging (DI) Market Size, Share, Trends and Analysis by Product Type, Region and Segment Forecast to 2033
Accessing the in-depth insights from the ‘Diagnostic Imaging’ market report can help you: Gain a valuable understanding of the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments. Identify competitors' capabilities to stay ahead in the market. Identify segments and get an understanding of various stakeholders. Anticipate changes in demand and adjust business development strategies. Identify potential regions and countries for growth opportunities. How is our ‘Diagnostic Imaging’ market report different from other reports...
-
Company Profile
Resonant Inc. – Company Profile
Resonant Inc (Resonant) carries out the development of filter designs for radio frequency (RF) front-ends for the mobile device industry. The company uses synthesized networks (ISN) technology to configure resonators of RF filters, which are used to select desired radio frequency signals and reject unwanted signals. It creates software, intellectual property (IP) and a services platform for radio frequency (RF) front-ends. The company’s proprietary design tools (ISN) is involved in single-band designs and multiplexer designs. Resonant also has advanced developments...
Add to Basket